Transverse myelitis in a patient with activated phosphoinositide 3-kinase δ syndrome type 1
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:219 |
|---|---|
| Enthalten in: |
Clinical immunology (Orlando, Fla.) - 219(2020) vom: 01. Okt., Seite 108552 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Orf, Kate [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case Reports |
|---|
| Anmerkungen: |
Date Completed 17.05.2021 Date Revised 17.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clim.2020.108552 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313336652 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313336652 | ||
| 003 | DE-627 | ||
| 005 | 20231225150345.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clim.2020.108552 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1044.xml |
| 035 | |a (DE-627)NLM313336652 | ||
| 035 | |a (NLM)32758532 | ||
| 035 | |a (PII)S1521-6616(20)30551-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Orf, Kate |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Transverse myelitis in a patient with activated phosphoinositide 3-kinase δ syndrome type 1 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.05.2021 | ||
| 500 | |a Date Revised 17.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Class I Phosphatidylinositol 3-Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.1.137 |2 NLM | |
| 700 | 1 | |a Abbas, Ahmed |e verfasserin |4 aut | |
| 700 | 1 | |a Abdel-Aziz, Khaled |e verfasserin |4 aut | |
| 700 | 1 | |a Burns, Siobhan O |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical immunology (Orlando, Fla.) |d 1999 |g 219(2020) vom: 01. Okt., Seite 108552 |w (DE-627)NLM098196855 |x 1521-7035 |7 nnns |
| 773 | 1 | 8 | |g volume:219 |g year:2020 |g day:01 |g month:10 |g pages:108552 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clim.2020.108552 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 219 |j 2020 |b 01 |c 10 |h 108552 | ||